Corient Capital Partners, LLC Bio Techne Corp Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 3,141 shares of TECH stock, worth $238,496. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,141
Previous 3,133
0.26%
Holding current value
$238,496
Previous $1.09 Million
0.28%
% of portfolio
0.08%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding TECH
# of Institutions
611Shares Held
149MCall Options Held
213KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.39 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.53MShares$647 Million0.07% of portfolio
-
State Street Corp Boston, MA6.3MShares$478 Million0.02% of portfolio
-
Bamco Inc New York, NY4.78MShares$363 Million1.0% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.98B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...